![Michael Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Kelly
Directeur/Membre du Conseil chez
ARS PHARMACEUTICALS, INC.
Fortune : 281 301 $ au 31/10/2026
Profil
Mr. Michael Kelly is an Independent Director at ARS Pharmaceuticals, Inc. He is on the Board of Directors at ARS Pharmaceuticals Operations, Inc. and ARS Pharmaceuticals, Inc. Mr. Kelly was previously employed as a President, Chief Executive Officer & Director by NervGen Pharma Corp., a President-US Operations by Adapt Pharma, Inc., a President by Covis Pharmaceuticals, Inc., a Senior Vice President-Sales & Marketing by Jazz Pharmaceuticals Plc, a Senior Vice President & General Manager by Azur Pharma, Inc., a Vice President-Commercial Operations by Guilford Pharmaceuticals, Inc., a Member by Azur Pharma Ltd., and a Vice President-Sales and Marketing by Viropharma, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from Rider University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/06/2026 | 83 225 ( 0,08% ) | 281 301 $ | 31/10/2026 |
Postes actifs de Michael Kelly
| Sociétés | Poste | Début |
|---|---|---|
| ARS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/05/2019 |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Directeur/Membre du Conseil | 01/05/2019 |
Anciens postes connus de Michael Kelly
| Sociétés | Poste | Fin |
|---|---|---|
| NERVGEN PHARMA CORP. | Directeur Général | 17/07/2025 |
Emergent Devices, Inc.
 Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur des opérations | 01/06/2019 |
Covis Pharmaceuticals, Inc.
 Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Directeur Général | 01/03/2016 |
Azur Pharma Ltd.
 Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 27/01/2012 |
Jazz Pharmaceuticals Commercial Corp.
 Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Corporate Officer/Principal | 01/01/2012 |
Formation de Michael Kelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
60
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs used to treat neurological diseases | Health Technology |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rider University
 Rider University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Azur Pharma Ltd.
Azur Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical services | Health Technology |
Jazz Pharmaceuticals Plc
 Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Covis Pharmaceuticals, Inc.
Covis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
NervGen Pharma Corp.
 NervGen Pharma Corp. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops neuroreparative therapeutics and pharmaceutical products for neurological disorders | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
Emergent Devices, Inc.
Emergent Devices, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Viropharma, Inc. |
